Indivior PLC Ordinary Shares (INDV) stock news · P/E 12, rev $1.24B
Indivior PLC Ordinary Shares (INDV) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This INDV news page leads with what Indivior PLC Ordinary Shares filed — not a scraped headline mill.
No cached 8-K sentence for INDV yet. We will not pad this page with generic market recap.
Latest reported INDV revenue for 2025-12-31 was $1.24B. Net income was $210.0M. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. INDV currently screens at market cap $4.48B and trailing P/E 11.6.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the INDV stock page; for the tape open the quote page.
INDV stock news FAQ
What are INDV's latest revenue and net income?
Latest cached Indivior PLC Ordinary Shares (INDV) revenue for Dec 31, 2025 was $1.24B. Net income was $210.0M. Statements: https://lician.com/financials/indv
How did INDV revenue change from the prior cached period?
Cached Indivior PLC Ordinary Shares (INDV) revenue was up 4.3% from $1.19B (Dec 31, 2024) to $1.24B (Dec 31, 2025). Statements: https://lician.com/financials/indv
What is INDV's P/E ratio?
Indivior PLC Ordinary Shares (INDV) trailing P/E is 11.6 on the latest cached fundamentals snapshot.
What is INDV's market cap?
Indivior PLC Ordinary Shares (INDV) market cap is $4.48B on the latest cached fundamentals snapshot.
What kind of company is INDV?
Indivior PLC Ordinary Shares (INDV) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Where is INDV stock news listed?
Cached stock news for Indivior PLC Ordinary Shares (INDV) is listed at https://lician.com/news/indv. Filings: https://lician.com/sec/indv
Not investment advice.